Astrana Health Future Growth
Future criteria checks 3/6
Astrana Health is forecast to grow earnings and revenue by 18.7% and 16% per annum respectively while EPS is expected to grow by 16.9% per annum.
Key information
18.7%
Earnings growth rate
16.9%
EPS growth rate
| Healthcare earnings growth | 19.3% |
| Revenue growth rate | 16.0% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 15 Aug 2024 |
Recent future growth updates
Recent updates
Is Astrana Health (NASDAQ:ASTH) Using Too Much Debt?
Aug 28
Astrana Health, Inc.'s (NASDAQ:ASTH) 29% Jump Shows Its Popularity With Investors
Aug 02Is There Now An Opportunity In Astrana Health, Inc. (NASDAQ:ASTH)?
Jun 19Capital Allocation Trends At Astrana Health (NASDAQ:ASTH) Aren't Ideal
Jun 02Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 09Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)
Apr 15At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely?
Feb 25Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?
Feb 07Apollo Medical Holdings: Good Company, Not Quite A Hold
Jan 17With Apollo Medical Holdings, Inc. (NASDAQ:AMEH) It Looks Like You'll Get What You Pay For
Dec 27Returns On Capital At Apollo Medical Holdings (NASDAQ:AMEH) Have Stalled
Nov 08Should You Investigate Apollo Medical Holdings, Inc. (NASDAQ:AMEH) At US$30.62?
Oct 26Apollo Medical Holdings (NASDAQ:AMEH) Has A Pretty Healthy Balance Sheet
Sep 22Returns At Apollo Medical Holdings (NASDAQ:AMEH) Appear To Be Weighed Down
Aug 04A Look At The Intrinsic Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)
Jul 19We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Stay On Top Of Its Debt
Jun 19Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher
May 05Does This Valuation Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Imply Investors Are Overpaying?
Apr 20Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?
Mar 21Apollo Medical Holdings (NASDAQ:AMEH) Has More To Do To Multiply In Value Going Forward
Jan 06Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?
Dec 16Apollo Medical to acquire Valley Oaks Medical Group
Oct 05Apollo Medical to acquire a San Francisco Bay area physicians' group, health plan
Sep 26A Look At The Fair Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)
Sep 21The Return Trends At Apollo Medical Holdings (NASDAQ:AMEH) Look Promising
Sep 06With EPS Growth And More, Apollo Medical Holdings (NASDAQ:AMEH) Makes An Interesting Case
Aug 22Apollo Medical Q2 GAAP EPS beats estimate, co reiterates FY 2022 revenue guidance
Aug 04Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?
Aug 04Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 2,717 | 97 | N/A | 147 | 4 |
| 12/31/2025 | 2,251 | 80 | 106 | 117 | 8 |
| 12/31/2024 | 1,818 | 63 | 78 | 98 | 7 |
| 6/30/2024 | 1,592 | 68 | 50 | 64 | N/A |
| 3/31/2024 | 1,454 | 62 | 52 | 66 | N/A |
| 12/31/2023 | 1,387 | 61 | 40 | 68 | N/A |
| 9/30/2023 | 1,328 | 45 | 112 | 134 | N/A |
| 6/30/2023 | 1,297 | 46 | 61 | 83 | N/A |
| 3/31/2023 | 1,218 | 45 | 46 | 66 | N/A |
| 12/31/2022 | 1,144 | 45 | 59 | 82 | N/A |
| 9/30/2022 | 1,045 | 58 | -40 | -15 | N/A |
| 6/30/2022 | 955 | 69 | 41 | 72 | N/A |
| 3/31/2022 | 861 | 70 | 48 | 84 | N/A |
| 12/31/2021 | 774 | 69 | 51 | 70 | N/A |
| 9/30/2021 | 756 | 70 | 63 | 80 | N/A |
| 6/30/2021 | 709 | 53 | 57 | 65 | N/A |
| 3/31/2021 | 698 | 47 | 64 | 65 | N/A |
| 12/31/2020 | 687 | 38 | 45 | 46 | N/A |
| 9/30/2020 | 689 | 35 | 52 | 52 | N/A |
| 6/30/2020 | 665 | 22 | 47 | 48 | N/A |
| 3/31/2020 | 630 | 18 | 7 | 8 | N/A |
| 12/31/2019 | 561 | 14 | 13 | 14 | N/A |
| 9/30/2019 | 488 | 4 | 3 | 4 | N/A |
| 6/30/2019 | 499 | 10 | -11 | -10 | N/A |
| 3/31/2019 | 492 | 9 | 16 | 17 | N/A |
| 12/31/2018 | 520 | 11 | 24 | 25 | N/A |
| 9/30/2018 | 506 | 28 | 46 | 47 | N/A |
| 6/30/2018 | 436 | 24 | 39 | 41 | N/A |
| 3/31/2018 | 395 | 24 | N/A | 35 | N/A |
| 12/31/2017 | 356 | 26 | N/A | 52 | N/A |
| 9/30/2017 | 336 | 13 | N/A | 44 | N/A |
| 6/30/2017 | 323 | 11 | N/A | 45 | N/A |
| 3/31/2017 | 317 | 12 | N/A | 47 | N/A |
| 12/31/2016 | 306 | 11 | N/A | 22 | N/A |
| 12/31/2015 | 313 | 13 | N/A | 32 | N/A |
| 12/31/2014 | 134 | -1 | N/A | 16 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ASTH's forecast earnings growth (18.7% per year) is above the savings rate (2.5%).
Earnings vs Market: ASTH's earnings (18.7% per year) are forecast to grow faster than the US market (15.2% per year).
High Growth Earnings: ASTH's earnings are forecast to grow, but not significantly.
Revenue vs Market: ASTH's revenue (16% per year) is forecast to grow faster than the US market (8.8% per year).
High Growth Revenue: ASTH's revenue (16% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ASTH's Return on Equity is forecast to be high in 3 years time